Under construction – not a live service
Sign in
Taking people in NetherlandsNo phase

Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH)

Key facts

Where
Breda, Leeuwarden, and Zwolle, NetherlandsSee the 3 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Source: NCT06342843, who can take part

Where in Netherlands

  • AmphiaBreda, NetherlandsContact: Stefan BT Bolder, MDTaking people
  • Medisch Centrum LeeuwardenLeeuwarden, NetherlandsContact: Wierd Zijlstra, MD/PhDTaking people
  • IsalaZwolle, NetherlandsContact: Diederik de Boer, MSc.Taking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Isala
Trial code
NCT06342843
Record updated
3 August 2025
Original description
This study will compare postoperative pain, health related quality of life (HRQoL), function, rehabilitation, urinary incontinence, muscle atrophy and component positioning in total hip arthroplasty (THA) using the posterolateral approach (PLA) or the direct superior approach (DSA). In addition, the CT images will be used to validate a new metal artefact reduction technique.Read full original descriptionShow less

Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty: a Multicenter Double Blinded Randomized Controlled Trial

This study will compare postoperative pain, health related quality of life (HRQoL), function, rehabilitation, urinary incontinence, muscle atrophy and component positioning in total hip arthroplasty (THA) using the posterolateral approach (PLA) or the direct superior approach (DSA). In addition, the CT images will be used to validate a new metal artefact reduction technique.

Inclusion: Subject; Has symptomatic incapacitating coxarthrosis in whom total hip arthroplasty (THA) is indicated, diagnosed by both physical examination and pelvic/hip X-ray; Has signed informed consent; Is ageing 18 years or older at time of study entry; Is competent and able to participate in follow-up.

Exclusion: Previous ipsilateral hip surgery; Neurological conditions influencing walking pattern; Cognitive impairment; Malignancies or metastases involving the hip joint or the nearby soft tissues; BMI >35 kg/m2; Contralateral incapacitating coxarthrosis, diagnosed by both physical examination and pelvic/hip X-ray; Inability to walk without walking aid preoperatively; Rheumatoid arthritis (RA); Severe hip dysplasia; Inability to speak and write Dutch language.

ClinicalTrials.gov NCT06342843